drugset / Trial / NCT00846872
Effect of Continuous GHRP-3 Infusion at on GH-IGF-I System, Blood Pressure, Glucose, and Insulin Resistance
Non-randomizedCrossoverSingle-blindOther
Summary
The hypothesis is that GHRP-3 will exert beneficial effects on endothelial function and insulin resistance in older men and women via hormonal (GH, IGF-I, IGFBP-3,-1, insulin) and non-hormonal actions (anti-inflammatory).
Timeline
- Start
- 2008-07
- Primary completion
- 2012-03
- Completion
- 2012-03
Outcome
Outcome not reported
Stopped (Enrollment): “Inadequate subject recruitment”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | GHRP-3 | Other / unclassified | 0.1 ug/kg | Subcutaneous |
| Comparator | GHRP-3 | Other / unclassified | 0.5 ug/kg | Subcutaneous |
Indications
No indication recorded.